Incidence of pulmonary vein stenosis in two types of cryoballoon systems.

Autor: Shiomi S; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Tokuda M; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Sakurai R; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Yamazaki Y; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Matsumoto T; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Sato H; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Oseto H; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Yokoyama M; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Tokutake K; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Kato M; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Yamashita S; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Yamane T; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan., Yoshimura M; The Department of Cardiology The Jikei University School of Medicine Tokyo Japan.
Jazyk: angličtina
Zdroj: Journal of arrhythmia [J Arrhythm] 2024 Jun 14; Vol. 40 (4), pp. 830-838. Date of Electronic Publication: 2024 Jun 14 (Print Publication: 2024).
DOI: 10.1002/joa3.13087
Abstrakt: Background: Currently, two types of cryoballoon (CB) systems are available for catheter ablation of atrial fibrillation (AF). Since the POLARx (Boston Scientific) is softer during freezing than the Arctic Front Advance Pro (AFA-Pro; Medtronic), it tends to go more deeply into the pulmonary vein (PV), risking PV stenosis.
Methods: Ninety-one patients underwent initial CB ablation for paroxysmal AF (AFA-Pro 56; POLARx 35). Twenty-six from each group were extracted using propensity score matching. The PV cross-sectional area (PVA) was measured by tracing the area within the PV plane at 5-mm intervals from the PV ostium in a distal direction for 20 mm or to the bifurcation in each PV. The PVA was compared before and 3 months after ablation.
Results: Time to balloon temperatures of -30 and - 40°C was significantly shorter and the nadir temperature was significantly lower with POLARx than with AFA-Pro. In the left inferior (LI) PV and right superior (RS) PV, the freezing balloon position was significantly deeper in POLARx than in AFA-pro. The freezing position in RSPV with mild to moderate narrowing was deeper than those without (10.2 ± 3.3 mm vs. 8.2 ± 1.8 mm, p  = .01). In RSPV, the reduction of PVA tended to be greater with the POLARx than with the AFA-Pro (26.1% ± 14.1% vs. 19.9% ± 10.3%, p  = .07).
Conclusion: There was no significant difference in the incidence of PV stenosis between POLARx and AFA-Pro. However, if POLARx goes deep into the PVs, we will still have to be careful.
Competing Interests: Michifumi Tokuda received a consulting fee from Medtronic and research funding from Japan Lifeline Co. LTD, and Teiichi Yamane received speaker honoraria from Medtronic Japan and research grants from Japan Lifeline Co. LTD. Other authors declare that they have no conflicts of interest.
(© 2024 The Author(s). Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.)
Databáze: MEDLINE